Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
November 21, 2022
Clinical and budget impact of various CRC screenings
From the Roth Group, Division of Public Health Sciences
Understanding radiation therapy practices
From the Roth Group, Division of Public Health Sciences
A look at emerging sickle cell disease therapies
Teams at the University of Washington School of Pharmacy and Fred Hutch will model the clinical and economic burden of sickle cell disease and the potential benefits of emerging therapies
7 lung cancer misconceptions
Myths and misinformation still keep many people in the dark – and that’s bad news for their health
Lung cancer: to screen or not to screen
From the Roth Group, Public Health Sciences Division
Fred Hutch at ASCO
Immunotherapy advances, insights into health economics and leadership awards dominate oncology gathering
Big study finds no rise in death risk among women who took hormone therapy
A new twist to menopausal hormone replacement dilemma
A model for progress in lung cancer survival
From the Roth and Ramsey Labs, Public Health Sciences Division
Dr. Marian Neuhouser takes office as president of the American Society for Nutrition
Celebrating faculty and staff achievements
Good News at Fred Hutch
Celebrating faculty and staff achievements
Good News at Fred Hutch
Celebrating faculty and staff achievements